Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
DOI:
https://doi.org/10.2298/ABS240605022JKeywords:
Galectin-1, galectin-3, galectin-8, extravillous trophobalst, choriocarcinoma cellsAbstract
Paper description:
- Expression profiling studies revealed the presence of galectin family members during gestation in the placenta under physiological and pathological conditions.
- By immunocytochemistry, PCR and Western blotting we investigated the expression and localization patterns of galectins -1, -3, -8 in the normal extravillous HTR-8/SVneo and choriocarcinoma cell lines JAR and JEG-3.
- Lower expression of galectin-1, -3, and -8 mRNA and protein were observed in JAR and JEG-3 cells compared to HTR-8/SVneo cells.
- Differences in expression and subcellular distribution suggest galectin involvement in the pathology of choriocarcinoma abundance of the ~40 kDa form in HTR-8/SVneo cells.
Abstract: Galectins are found in the placenta during both normal and pathological conditions. Specifically, galectins -1, -3, and -8 have been identified in extravillous trophoblast cells, with galectins -1, and -3 playing notable roles in trophoblast cell function. Altered expression profiles of galectins are linked to various cancers. This study explores the expression and localization of galectins -1, -3, and -8 in a normal extravillous HTR-8/SVneo cell line and two choriocarcinoma cell lines, JAR and JEG-3. Expression levels of these galectins at both mRNA and protein levels were evaluated using PCR, qPCR, and Western blotting, while their cellular localization and distribution were assessed through immunocytochemistry, subcellular fractionation, and Western blotting. Galectins -1, -3, and -8 were expressed at lower levels in JAR and JEG-3 cells compared to HTR-8/SVneo cells. Additionally, different splice variants of galectin-8 were detected across all cell lines. Galectin-1 was predominantly localized at the plasma membrane. Notable differences in galectin-3 localization and distribution were observed between HTR-8/SVneo cells and choriocarcinoma cells. These findings highlight variations in the expression, staining patterns, and subcellular distribution of galectins -1, -3, and -8, suggesting their potential involvement in the pathology of choriocarcinoma.
Downloads
References
Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol . 2007;5(1):6. https://doi.org/10.1186/1477-7827-5-6
Blidner AG, Rabinovich GA. “Sweetening” Pregnancy: Galectins at the Fetomaternal Interface. Am J Reprod Immunol. 2013;69(4):369–82. https://doi.org/10.1111/AJI.12090
Tirado-González I, Freitag N, Barrientos G, Shaikly V, Nagaeva O, Strand M, Kjellberg L, Klapp BF, Mincheva-Nilsson L, Cohen M, Blois SM. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy. Mol Hum Reprod. 2013;19(1):43-53. https://doi.org/10.1093/molehr/gas043
Barrientos G, Freitag N, Tirado-González I, Unverdorben L, Jeschke U, Thijssen VLJLJL, Blois SM. Involvement of galectin-1 in reproduction: past, present and future. Hum Reprod Update. 2014;20(2):175-93. https://doi.org/10.1093/humupd/dmt040
Vićovac L, Janković M, Čuperlović M. Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod. 1998;13(3):730-5. https://doi.org/10.1093/humrep/13.3.730
Balogh A, Toth E, Romero R, Parej K, Csala D, Szenasi NL, Hajdu I, Juhasz K, Kovacs AF, Meiri H, Hupuczi P, Tarca AL, Hassan SS, Erez O, Zavodszky P, Matko J, Papp Z, Rossi SW, Hahn S, Pallinger E, Than NG. Placental galectins are key players in regulating the maternal adaptive immune response. Front Immunol. 2019;10(JUN):1240. https://doi.org/10.3389/fimmu.2019.01240
Blois SM, Dveksler G, Vasta GR, Freitag N, Blanchard V, Barrientos G. Pregnancy galectinology: Insights into a complex network of glycan binding proteins. Front Immunol. 2019;10:1166. https://doi.org/10.3389/fimmu.2019.01166
Maquoi E, Van den Brule FA, Castronovo V, Foidart JM. Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta. 1997;18(5-6):433-9. https://doi.org/10.1016/s0143-4004(97)80044-6
Than NG, Romero R, Goodman M, Weckle A, Xing J, Dong Z, Xu Y, Tarquini F, Szilagyi A, Gal P, Hou Z, Tarca AL, Kim CJ, Kim J-SS, Haidarian S, Uddin M, Bohn H, Benirschke K, Santolaya-Forgas J, Grossman LI, Erez O, Hassan SS, Zavodszky P, Papp Z, Wildman DE, Chong JK, Kim J-SS, Haidarian S, Uddin M, Bohn H, Benirschke K, Santolaya-Forgas J, Grossman LI, Erez O, Hassan SS, Zavodszky P, Papp Z, Wildman DE. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci U S A. 2009;106(24):9731-6. https://doi.org/10.1073/pnas.0903568106
Unverdorben L, Jeschke U, Santoso L, Hofmann S, Kuhn C, Arck P, Hutter S. Comparative analyses on expression of galectins1-4, 7-10 and 12 in first trimester placenta, decidua and isolated trophoblast cells in vitro. Histol Histopathol. 2016;31(10):1095-111. https://doi.org/10.14670/hh-11-739
Kolundžić N, Bojić-Trbojević Ž, Kovačević T, Stefanoska I, Kadoya T, Vićovac L. Galectin-1 is part of human trophoblast invasion machinery - A functional study in vitro. PLoS One. 2011;6(12):e28514. https://doi.org/10.1371/journal.pone.0028514
Kolundžić N, Bojić-Trbojević Ž, Radojčić L, Petronijević M, Vićovac L. Galectin-8 is expressed by villous and extravillous trophoblast of the human placenta. Placenta. 2011;32(11):909-11. https://doi.org/10.1016/j.placenta.2011.07.087
Bojić-Trbojević Ž, Jovanović Krivokuća M, Vilotić A, Kolundžić N, Stefanoska I, Zetterberg F, Nilsson UJ, Leffler H, Vićovac L. Human trophoblast requires galectin-3 for cell migration and invasion. Sci Rep. 2019;9(1):2136. https://doi.org/10.1038/s41598-018-38374-w
Božić M, Petronijević M, Milenković S, Atanacković J, Lazić J, Vićovac L. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta. 2004;25(10):797-802. https://doi.org/10.1016/j.placenta.2004.03.006
Liu A-XX, Jin F, Zhang W-WW, Zhou T-HH, Zhou C-YY, Yao W-MM, Qian Y-LL, Huang H-FF. Proteomic Analysis on the Alteration of Protein Expression in the Placental Villous Tissue of Early Pregnancy Loss. Biol Reprod. 2006;75(3):414-20. https://doi.org/10.1095/biolreprod.105.049379
Jeschke U, Mayr D, Schiessl B, Mylonas I, Schulze S, Kuhn C, Friese K, Walzel H. Expression of Galectin-1, -3 (gal-1, gal-3) and the Thomsen–Friedenreich (TF) Antigen in Normal, IUGR, Preeclamptic and HELLP Placentas. Placenta. 2007;28(11-12):1165-73. https://doi.org/10.1016/j.placenta.2007.06.006
Ramhorst RE, Giribaldi L, Fraccaroli L, Toscano MA, Stupirski JC, Romero MD, Durand ES, Rubinstein N, Blaschitz A, Sedlmayr P, Genti-Raimondi S, Fainboim L, Rabinovich GA. Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss. Glycobiology. 2012;22(10):1374-86. https://doi.org/10.1093/glycob/cws104
Benirschke K, Kaufmann P, editors. Pathology of the human placenta. 4th ed. Springer; 2000.
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynecol Obstet. 2018;143(S2):79-85. https://doi.org/10.1002/ijgo.12615
Elola MT, Ferragut F, Cárdenas Delgado VM, Nugnes LG, Gentilini L, Laderach D, Troncoso MF, Compagno D, Wolfenstein-Todel C, Rabinovich GA. Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors. Histol Histopathol. 2014;29(9):1093-105. https://doi.org/10.14670/hh-29.1093
Jeethy Ram T, Lekshmi A, Somanathan T, Sujathan K. Galectin-3: A factotum in carcinogenesis bestowing an archery for prevention. Tumor Biol. 2021;43(1):77-96. https://doi.org/10.3233/tub-200051
Nanami T, Hoshino I, Shiratori F, Yajima S, Oshima Y, Suzuki T, Ito M, Hiwasa T, Kuwajima A, Shimada H. Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker. Mol Clin Oncol. 2021;15(3). https://doi.org/10.3892/mco.2021.2341
Thijssen VL, Hulsmans S, Griffioen AW. The Galectin Profile of the Endothelium : Altered Expression and Localization in Activated and Tumor Endothelial Cells. Am J Pathol. 2008;172(2):545-53. https://doi.org/10.2353/ajpath.2008.070938
Kolundžić N, Ćujić D, Abu Rabi T, Bojić-Trbojević Ž, Kadoya T, Vićovac L. Galectin signature of the choriocarcinoma JAr cells: Galectin-1 as a modulator of invasiveness in vitro. Mol Reprod Dev. 2015;82(10):765-73. https://doi.org/10.1002/mrd.22515
Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol. 2001;127(6):375-86. https://doi.org/10.1007/s004320000207
Satelli A, Rao PS, Gupta PK, Lockman PR, Srivenugopal KS, Rao US. Varied expression and localization of multiple galectins in different cancer cell lines. Oncol Rep. 2008;19(3):587-94. https://doi.org/10.3892/or.19.3.587
Chetry M, Song Y, Pan C, Li R, Zhang J, Zhu X. Effects of Galectin-1 on Biological Behavior in Cervical Cancer. J Cancer. 2020;11(6):1584. https://doi.org/10.7150/JCA.38538
Bidon N, Brichory F, Hanash S, Bourguet P, Dazord L, Le Pennec JP. Two messenger RNAs and five isoforms for Po66-CBP, a galectin-8 homolog in a human lung carcinoma cell line. Gene. 2001;274(1-2):253-62. https://doi.org/10.1016/s0378-1119(01)00598-4
Roy M, Nguimbus LM, Badiane PY, Goguen-Couture V, Degrandmaison J, Parent JL, Brunet MA, Roux S. Galectin-8 modulates human osteoclast activity partly through isoform-specific interactions. Life Sci alliance. 2024;7(5):e202302348. https://doi.org/10.26508/LSA.202302348
Vyakarnam A, Lenneman AJ, Lakkides KM, Patterson RJ, Wang JL. A Comparative Nuclear Localization Study of Galectin-1 with Other Splicing Components. Exp Cell Res. 1998;242(2):419-28. https://doi.org/10.1006/excr.1998.4111
Dagher SF, Wang JL, Patterson RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A. 1995;92(4):1213-7. https://doi.org/10.1073/pnas.92.4.1213
Nagy N, Bronckart Y, Camby I, Legendre H, Lahm H, Kaltner H, Hadari Y, P VH, Yeaton P, Pector J-C, Zick Y, Salmon I, Danguy A, Kiss R, Gabius H-JJ, Van Ham P, Yector JC, Zeaton P, Pick Y, Salmon I, Danguy A, Kiss R, Gabius H-JJ. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor. Gut. 2002;50(3):392-401. https://doi.org/10.1136/gut.50.3.392
Zick Y, Eisenstein M, Goren RA, Hadari YR, Levy Y, Ronen D. Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J. 2002;19(7-9):517-26. https://doi.org/10.1023/b:glyc.0000014081.55445.af
Ozeki Y, Matsui T, Yamamoto Y, Funahashi M, Hamako J, Titani K. Tissue fibronectin is an endogenous ligand for galectin-1. Glycobiology. 1995;5(2):255-61. https://doi.org/10.1093/GLYCOB/5.2.255
Bojić-Trbojević Ž, Jovanović Krivokuća M, Stefanoska I, Kolundzić N, Vilotić A, Kadoya T, Vićovac L. Integrin β1 is bound to galectin-1 in human trophoblast. J Biochem . 2018;163(1):39-50. 1. Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol. 2007;5(1):6. https://doi.org/10.1186/1477-7827-5-6
Bojić-Trbojević Ž, Jovanović Krivokuća M, Kolundžić N, Petronijević M, Vrzić-Petronijević S, Golubović S, Vićovac L. Galectin-1 binds mucin in human trophoblast. Histochem Cell Biol. 2014;142(5):541-53. https://doi.org/10.1007/S00418-014-1229-7
Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Anti-galectin compounds as potential anti-cancer drugs. Curr Med Chem. 2006;13(29):3513-27. https://doi.org/10.2174/092986706779026219
Sethi A, Sanam S, Alvala R, Alvala M. An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present). Expert Opin Ther Pat. 2021;31(8):709-21. https://doi.org/10.1080/13543776.2021.1903430
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Milica Jovanović Krivokuća, Janko Legner, Danica Ćujić, Aleksandra Vilotić, Ivana Grubiša, Ljiljana Vićovac, Žanka Bojić-Trbojević
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
